Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2020

Nov 16, 2020

SELL
$16.2 - $25.7 $2.07 Million - $3.29 Million
-127,900 Closed
0 $0
Q2 2020

Aug 14, 2020

BUY
$5.24 - $23.4 $670,196 - $2.99 Million
127,900 New
127,900 $2.99 Million
Q2 2019

Aug 14, 2019

SELL
$3.84 - $6.4 $756,145 - $1.26 Million
-196,913 Closed
0 $0
Q1 2019

May 14, 2019

BUY
$3.51 - $7.3 $691,164 - $1.44 Million
196,913 New
196,913 $1.04 Million

Others Institutions Holding MRSN

About Mersana Therapeutics, Inc.


  • Ticker MRSN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 97,169,296
  • Market Cap $215M
  • Description
  • Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...
More about MRSN
Track This Portfolio

Track Pura Vida Investments, LLC Portfolio

Follow Pura Vida Investments, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Pura Vida Investments, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Pura Vida Investments, LLC with notifications on news.